BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28934183)

  • 61. Spatial evaluation of prevalence, pattern and predictors of cervical cancer screening in India.
    Nilima ; Puranik A; Shreenidhi SM; Rai SN
    Public Health; 2020 Jan; 178():124-136. PubMed ID: 31678693
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Organizational Factors Associated with Disparities in Cervical and Colorectal Cancer Screening Rates in Community Health Centers.
    Chuang E; Pourat N; Chen X; Lee C; Zhou W; Daniel M; Hoang H; Sripipatana A
    J Health Care Poor Underserved; 2019; 30(1):161-181. PubMed ID: 30827976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Disparities in cervical cancer screening in the United States.
    Lepe M
    Cancer Cytopathol; 2024 Apr; 132(4):205-208. PubMed ID: 37519242
    [No Abstract]   [Full Text] [Related]  

  • 64. Patterns and Trends in Cancer Screening in the United States.
    Hall IJ; Tangka FKL; Sabatino SA; Thompson TD; Graubard BI; Breen N
    Prev Chronic Dis; 2018 Jul; 15():E97. PubMed ID: 30048233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013.
    Tanaka Y; Ueda Y; Kishida H; Hosogai N; Morimoto A; Egawa-Takata T; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
    Int J Clin Oncol; 2015 Dec; 20(6):1156-60. PubMed ID: 25990449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.
    Pruitt SL; Werner CL; Borton EK; Sanders JM; Balasubramanian BA; Barnes A; Betts AC; Skinner CS; Tiro JA
    Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1398-1406. PubMed ID: 30185535
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Racial/ethnic inequalities in cervical cancer screening in the United States: An outcome reclassification to better inform interventions and benchmarks.
    Datta GD; Pana MP; Mayrand MH; Glenn B
    Prev Med; 2022 Jun; 159():107055. PubMed ID: 35460715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics.
    Salomon SG; Torrone E; Nakatsukasa-Ono W; Fine DN
    Sex Transm Dis; 2017 Sep; 44(9):519-523. PubMed ID: 28809768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CDC Grand Rounds: the future of cancer screening.
    Thomas CC; Richards TB; Plescia M; Wong FL; Ballard R; Levin TR; Calonge BN; Brawley OW; Iskander J;
    MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(12):324-7. PubMed ID: 25837243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adapting a Cancer Screening Education Program for Native American Women with Disabilities.
    Armin JS; Williamson HJ; Begay A; Etcitty J; Attakai A; Russell K; Baldwin JA
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954636
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Six Tips for Giving Good Health Care to Anyone With a Cervix.
    Sallans RK
    AMA J Ethics; 2020 Feb; 22(2):E168-175. PubMed ID: 32048589
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Who are the under- and never-screened for cancer in Ontario: a qualitative investigation.
    Gesink D; Mihic A; Antal J; Filsinger B; Racey CS; Perez DF; Norwood T; Ahmad F; Kreiger N; Ritvo P
    BMC Public Health; 2014 May; 14():495. PubMed ID: 24885998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines.
    Salingaros S; Shieh Y; Finkel ML; Polaneczky M; Korenstein D; Marti JL
    J Med Screen; 2024 Mar; ():9691413241238960. PubMed ID: 38504656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Community Health Centers' Performance in Cancer Screening and Prevention.
    Huguet N; Hodes T; Holderness H; Bailey SR; DeVoe JE; Marino M
    Am J Prev Med; 2022 Feb; 62(2):e97-e106. PubMed ID: 34663549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity.
    Saraiya M; Colbert J; Bhat GL; Almonte R; Winters DW; Sebastian S; O'Hanlon M; Meadows G; Nosal MR; Richards TB; Michaels M; Townsend JS; Miller JW; Perkins RB; Sawaya GF; Wentzensen N; White MC; Richardson LC
    J Womens Health (Larchmt); 2022 Apr; 31(4):462-468. PubMed ID: 35467443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictors of cervical cancer screening adherence in the United States: a systematic review.
    Limmer K; LoBiondo-Wood G; Dains J
    J Adv Pract Oncol; 2014 Jan; 5(1):31-41. PubMed ID: 25032031
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predicting cervical cancer screening among sexual minority women using Classification and Regression Tree analysis.
    Greene MZ; Hughes TL; Hanlon A; Huang L; Sommers MS; Meghani SH
    Prev Med Rep; 2019 Mar; 13():153-159. PubMed ID: 30591857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. American Cancer Society guidelines for the early detection of cancer, 2004.
    Smith RA; Cokkinides V; Eyre HJ;
    CA Cancer J Clin; 2004; 54(1):41-52. PubMed ID: 14974763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A qualitative study of primary care clinician's approach to ending cervical cancer screening in older women in the United States.
    Holt HK; Flores R; James JE; Waters C; Kaplan CP; Peterson CE; Sawaya GF
    Prev Med Rep; 2023 Dec; 36():102500. PubMed ID: 38116273
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.